Literature DB >> 24133186

Antiretroviral treatment, preexposure prophylaxis, and drug resistance in sub-Saharan Africa: a consensus among mathematical models.

Ume L Abbas1, Robert Glaubius, Gregory Hood, John W Mellors.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24133186     DOI： 10.1093/infdis/jit545

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  8 in total

1.  Emerging antiretroviral drug resistance in sub-Saharan Africa: novel affordable technologies are needed to provide resistance testing for individual and public health benefits.

Authors:  Gert U van Zyl; Lisa M Frenkel; Michael H Chung; Wolfgang Preiser; John W Mellors; Jean B Nachega
Journal:  AIDS       Date:  2014-11-28       Impact factor: 4.177

Review 2.  Should we fear resistance from tenofovir/emtricitabine preexposure prophylaxis?

Authors:  Urvi M Parikh; John W Mellors
Journal:  Curr Opin HIV AIDS       Date:  2016-01       Impact factor: 4.283

3.  Estimation and Short-Term Prediction of the Course of the HIV Epidemic Using Demographic and Health Survey Methodology-Like Data.

Authors:  Stéphanie Blaizot; Benjamin Riche; David Maman; Irene Mukui; Beatrice Kirubi; Jean-François Etard; René Ecochard
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

Review 4.  Lessons from a decade of voluntary medical male circumcision implementation and their application to HIV pre-exposure prophylaxis scale up.

Authors:  Jason B Reed; Rupa R Patel; Rachel Baggaley
Journal:  Int J STD AIDS       Date:  2018-08-16       Impact factor: 1.359

Review 5.  The impact, cost and cost-effectiveness of oral pre-exposure prophylaxis in sub-Saharan Africa: a scoping review of modelling contributions and way forward.

Authors:  Kelsey K Case; Gabriela B Gomez; Timothy B Hallett
Journal:  J Int AIDS Soc       Date:  2019-09       Impact factor: 5.396

6.  Cost-effectiveness of Injectable Preexposure Prophylaxis for HIV Prevention in South Africa.

Authors:  Robert L Glaubius; Greg Hood; Kerri J Penrose; Urvi M Parikh; John W Mellors; Eran Bendavid; Ume L Abbas
Journal:  Clin Infect Dis       Date:  2016-05-18       Impact factor: 20.999

7.  How could preventive therapy affect the prevalence of drug resistance? Causes and consequences.

Authors:  Amber Kunkel; Caroline Colijn; Marc Lipsitch; Ted Cohen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-06-05       Impact factor: 6.237

8.  Deciphering the Effects of Injectable Pre-exposure Prophylaxis for Combination Human Immunodeficiency Virus Prevention.

Authors:  Robert L Glaubius; Urvi M Parikh; Greg Hood; Kerri J Penrose; Eran Bendavid; John W Mellors; Ume L Abbas
Journal:  Open Forum Infect Dis       Date:  2016-06-16       Impact factor: 4.423
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.